Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Tandem Diabetes Care, Inc. | TNDM | $16.35 | $1.14B | — | |
| IRADIMED CORPORATION | IRMD | $87.81 | $1.12B | 49.1 | 0.91% |
| Vor Biopharma Inc. | VOR | $18.94 | $1.12B | — | — |
| Artivion, Inc. | AORT | $22.90 | $1.12B | — | |
| Amphastar Pharmaceuticals, Inc. | AMPH | $26.20 | $1.11B | 15.5 | — |
| Avalyn Pharma Inc. | AVLN | $25.11 | $1.11B | — | |
| Replimune Group, Inc. | REPL | $11.72 | $1.10B | — | |
| WELL Health Technologies Corp. | WELL.TO | CA$4.31 | CA$1.10B | 215.5 | — |
| Akso Health Group | AHG | $1.27 | $1.09B | — | |
| STAAR Surgical Company | STAA | $21.61 | $1.08B | 270.1 | — |
| Latigo Biotherapeutics, Inc. | LTGO | $16.34 | $1.08B | — | |
| Harrow, Inc. | HROW | $28.24 | $1.06B | — | |
| Seaport Therapeutics, Inc. | SPTX | $19.73 | $1.06B | — | |
| Castle Biosciences, Inc. | CSTL | $34.37 | $1.05B | — | |
| PROCEPT BioRobotics Corporation | PRCT | $18.27 | $1.04B | — | |
| Lumexa Imaging Holdings, Inc. | LMRI | $10.81 | $1.04B | — | |
| Janux Therapeutics, Inc. | JANX | $16.93 | $1.04B | — | |
| HealthStream, Inc. | HSTM | $33.51 | $1.03B | 46.5 | 0.40% |
| CeriBell, Inc. | CBLL | $27.14 | $1.01B | — | |
| MannKind Corporation | MNKD | $3.05 | $980.71M | — | |
| QuidelOrtho Corporation | QDEL | $14.08 | $965.54M | — | |
| Jade Biosciences, Inc. | JBIO | $15.13 | $962.23M | — | |
| Savara Inc. | SVRA | $4.67 | $959.50M | — | |
| Monte Rosa Therapeutics, Inc. | GLUE | $11.22 | $957.22M | — | |
| MeiraGTx Holdings plc | MGTX | $9.86 | $946.98M | 11.3 | — |
| ArriVent BioPharma, Inc. | AVBP | $19.12 | $942.76M | — | |
| SI-BONE, Inc. | SIBN | $20.82 | $933.12M | — | |
| SpyGlass Pharma, Inc. | SGP | $27.71 | $926.84M | — | |
| Bioventus Inc. | BVS | $14.24 | $926.22M | 17.4 | — |
| Integra LifeSciences Holdings Corporation | IART | $11.84 | $920.83M | — | |
| Alto Neuroscience, Inc. | ANRO | $23.32 | $915.13M | — | |
| Aktis Oncology, Inc. | AKTS | $16.42 | $913.27M | — | |
| Odyssey Therapeutics, Inc. | ODTX | $19.00 | $913.11M | — | |
| Rigel Pharmaceuticals, Inc. | RIGL | $48.88 | $913.07M | 2.9 | — |
| MoonLake Immunotherapeutics | MLTX | $10.65 | $906.39M | — | |
| Beta Bionics, Inc. | BBNX | $18.40 | $882.02M | — | |
| Alumis Inc. | ALMS | $6.81 | $881.45M | — | |
| Kura Oncology, Inc. | KURA | $9.88 | $878.93M | — | |
| Cullinan Therapeutics, Inc. | CGEM | $14.89 | $866.56M | — | |
| Obsidian Therapeutics, Inc. | OBX | $13.93 | $860.50M | — | |
| Corvus Pharmaceuticals, Inc. | CRVS | $10.05 | $845.42M | — | |
| Inventiva S.A. | IVA | $3.55 | $838.58M | — | |
| P3 Health Partners Inc. | PIII | $4.11 | $837.57M | — | |
| Verastem, Inc. | VSTM | $9.21 | $834.09M | — | |
| AdaptHealth Corp. | AHCO | $6.10 | $813.80M | — | |
| SL Science Holding Limited | SLBT | $1.45 | $813.10M | — | |
| Ardelyx, Inc. | ARDX | $3.13 | $808.13M | — | |
| InMode Ltd. | INMD | $14.03 | $807.34M | 11.6 | — |
| Cybin D/B/A Helus Pharma | HELP | $10.78 | $787.59M | — | |
| Apnimed, Inc. | APMD | $18.90 | $786.82M | 2.6 | — |
Tandem Diabetes Care, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.14B
- P/E
- unprofitable
IRADIMED CORPORATION
Healthcare / Medical Devices
- Market Cap
- $1.12B
- P/E
- 49.1
- Dividend Yield
- 0.91%
Vor Biopharma Inc.
Healthcare / Biotechnology
- Market Cap
- $1.12B
Artivion, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.12B
- P/E
- unprofitable
Amphastar Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.11B
- P/E
- 15.5
Avalyn Pharma Inc.
Healthcare / Biotechnology
- Market Cap
- $1.11B
- P/E
- unprofitable
Replimune Group, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.10B
- P/E
- unprofitable
WELL Health Technologies Corp.
Healthcare / Medical Care Facilities
- Market Cap
- CA$1.10B
- P/E
- 215.5
Akso Health Group
Healthcare / Medical Distribution
- Market Cap
- $1.09B
- P/E
- unprofitable
STAAR Surgical Company
Healthcare / Medical Instruments & Supplies
- Market Cap
- $1.08B
- P/E
- 270.1
Latigo Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.08B
- P/E
- unprofitable
Harrow, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.06B
- P/E
- unprofitable
Seaport Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.06B
- P/E
- unprofitable
Castle Biosciences, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $1.05B
- P/E
- unprofitable
PROCEPT BioRobotics Corporation
Healthcare / Medical Devices
- Market Cap
- $1.04B
- P/E
- unprofitable
Lumexa Imaging Holdings, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.04B
- P/E
- unprofitable
Janux Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.04B
- P/E
- unprofitable
HealthStream, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.03B
- P/E
- 46.5
- Dividend Yield
- 0.40%
CeriBell, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.01B
- P/E
- unprofitable
MannKind Corporation
Healthcare / Biotechnology
- Market Cap
- $980.71M
- P/E
- unprofitable
QuidelOrtho Corporation
Healthcare / Medical Devices
- Market Cap
- $965.54M
- P/E
- unprofitable
Jade Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $962.23M
- P/E
- unprofitable
Savara Inc.
Healthcare / Biotechnology
- Market Cap
- $959.50M
- P/E
- unprofitable
Monte Rosa Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $957.22M
- P/E
- unprofitable
MeiraGTx Holdings plc
Healthcare / Biotechnology
- Market Cap
- $946.98M
- P/E
- 11.3
ArriVent BioPharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $942.76M
- P/E
- unprofitable
SI-BONE, Inc.
Healthcare / Medical Devices
- Market Cap
- $933.12M
- P/E
- unprofitable
SpyGlass Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $926.84M
- P/E
- unprofitable
Bioventus Inc.
Healthcare / Medical Devices
- Market Cap
- $926.22M
- P/E
- 17.4
Integra LifeSciences Holdings Corporation
Healthcare / Medical Devices
- Market Cap
- $920.83M
- P/E
- unprofitable
Alto Neuroscience, Inc.
Healthcare / Biotechnology
- Market Cap
- $915.13M
- P/E
- unprofitable
Aktis Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $913.27M
- P/E
- unprofitable
Odyssey Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $913.11M
- P/E
- unprofitable
Rigel Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $913.07M
- P/E
- 2.9
MoonLake Immunotherapeutics
Healthcare / Biotechnology
- Market Cap
- $906.39M
- P/E
- unprofitable
Beta Bionics, Inc.
Healthcare / Medical Devices
- Market Cap
- $882.02M
- P/E
- unprofitable
Alumis Inc.
Healthcare / Biotechnology
- Market Cap
- $881.45M
- P/E
- unprofitable
Kura Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $878.93M
- P/E
- unprofitable
Cullinan Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $866.56M
- P/E
- unprofitable
Obsidian Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $860.50M
- P/E
- unprofitable
Corvus Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $845.42M
- P/E
- unprofitable
Inventiva S.A.
Healthcare / Biotechnology
- Market Cap
- $838.58M
- P/E
- unprofitable
P3 Health Partners Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $837.57M
- P/E
- unprofitable
Verastem, Inc.
Healthcare / Biotechnology
- Market Cap
- $834.09M
- P/E
- unprofitable
AdaptHealth Corp.
Healthcare / Medical Devices
- Market Cap
- $813.80M
- P/E
- unprofitable
SL Science Holding Limited
Healthcare / Biotechnology
- Market Cap
- $813.10M
- P/E
- unprofitable
Ardelyx, Inc.
Healthcare / Biotechnology
- Market Cap
- $808.13M
- P/E
- unprofitable
InMode Ltd.
Healthcare / Medical Devices
- Market Cap
- $807.34M
- P/E
- 11.6
Cybin D/B/A Helus Pharma
Healthcare / Biotechnology
- Market Cap
- $787.59M
- P/E
- unprofitable
Apnimed, Inc.
Healthcare / Biotechnology
- Market Cap
- $786.82M
- P/E
- 2.6
Showing 351–400 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.